Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting the Bcl-2 Family in B Cell Lymphoma
Clare M. Adams, Sean Clark-Garvey, Pierluigi Porcu, et al.
Frontiers in Oncology (2019) Vol. 8
Open Access | Times Cited: 136

Showing 1-25 of 136 citing articles:

Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia
Courtney D. DiNardo, Brian A. Jonas, Vinod Pullarkat, et al.
New England Journal of Medicine (2020) Vol. 383, Iss. 7, pp. 617-629
Open Access | Times Cited: 1947
The role of BCL-2 family proteins in regulating apoptosis and cancer therapy
Shanna Qian, Wei Zhong, Wanting Yang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 430
BCL-2 protein family: attractive targets for cancer therapy
Deeksha Kaloni, Sarah T. Diepstraten, Andreas Strasser, et al.
APOPTOSIS (2022) Vol. 28, Iss. 1-2, pp. 20-38
Open Access | Times Cited: 270
The PI3K-Akt-mTOR Signaling Pathway in Human Acute Myeloid Leukemia (AML) Cells
Ina Nepstad, Kimberley Joanne Hatfield, Ida Sofie Grønningsæter, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 8, pp. 2907-2907
Open Access | Times Cited: 243
Targeting BCL-2 in B-cell malignancies and overcoming therapeutic resistance
Isha Kapoor, Juraj Bodo, Brian T. Hill, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 11
Open Access | Times Cited: 196
Protein tyrosine kinase inhibitor resistance in malignant tumors: molecular mechanisms and future perspective
Yang Yang, Shuo Li, Yujiao Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 141
Hallmarks of cancer resistance
Muhammad Tufail, Jia-Ju Hu, Jie Liang, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109979-109979
Open Access | Times Cited: 18
High-resolution genome-wide mapping of chromosome-arm-scale truncations induced by CRISPR–Cas9 editing
Nathan H. Lazar, Safiye Çelik, Lu Chen, et al.
Nature Genetics (2024) Vol. 56, Iss. 7, pp. 1482-1493
Open Access | Times Cited: 17
The role of mitochondria-associated membranes in cellular homeostasis and diseases
Mariasole Perrone, Natascia Caroccia, Ilaria Genovese, et al.
International review of cell and molecular biology (2019), pp. 119-196
Open Access | Times Cited: 101
Mitochondria Associated Membranes (MAMs): Architecture and physiopathological role
Lucia Barazzuol, Flavia Giamogante, Tito Calì
Cell Calcium (2021) Vol. 94, pp. 102343-102343
Closed Access | Times Cited: 100
Exploiting Mitochondrial Vulnerabilities to Trigger Apoptosis Selectively in Cancer Cells
Christopher Nguyen, Siyaram Pandey
Cancers (2019) Vol. 11, Iss. 7, pp. 916-916
Open Access | Times Cited: 80
Stripenn detects architectural stripes from chromatin conformation data using computer vision
Sora Yoon, Aditi Chandra, Golnaz Vahedi
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 47
Doxorubicin-conjugated siRNA lipid nanoparticles for combination cancer therapy
Kamila Butowska, Xuexiang Han, Ningqiang Gong, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 4, pp. 1429-1437
Open Access | Times Cited: 39
Selective MCL-1 inhibitor ABBV-467 is efficacious in tumor models but is associated with cardiac troponin increases in patients
Junichiro Yuda, Christine Will, Darren C. Phillips, et al.
Communications Medicine (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 29
Blastic plasmacytoid dendritic cell neoplasm: a comprehensive review in pediatrics, adolescents, and young adults (AYA) and an update of novel therapies
Branko Cuglievan, Jeremy Connors, Jiasen He, et al.
Leukemia (2023) Vol. 37, Iss. 9, pp. 1767-1778
Open Access | Times Cited: 23
Comparative analysis of Bcl-2 family protein overexpression in CAR T cells alone and in combination with BH3 mimetics
Felix Korell, Michael Olson, Diego Salas‐Benito, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 750
Closed Access | Times Cited: 8
Context is everything: extrinsic signalling and gain-of-function p53 mutants
Ivano Amelio, Gerry Melino
Cell Death Discovery (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 52
Interactions of multidomain pro-apoptotic and anti-apoptotic proteins in cancer cell death
Alexander Chota, Blassan P. George, Heidi Abrahamse
Oncotarget (2021) Vol. 12, Iss. 16, pp. 1615-1626
Open Access | Times Cited: 50
Repositioning Lidocaine as an Anticancer Drug: The Role Beyond Anesthesia
Daipeng Zhou, Lei Wang, Qingbin Cui, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 41
p53 Isoforms as Cancer Biomarkers and Therapeutic Targets
Liuqun Zhao, Suparna Sanyal
Cancers (2022) Vol. 14, Iss. 13, pp. 3145-3145
Open Access | Times Cited: 27
Oridonin derivatives as potential anticancer drug candidates triggering apoptosis through mitochondrial pathway in the liver cancer cells
Dongdong Luo, Yujiao Yi, Kai Peng, et al.
European Journal of Medicinal Chemistry (2019) Vol. 178, pp. 365-379
Closed Access | Times Cited: 42
Interorganellar calcium signaling in the regulation of cell metabolism: A cancer perspective
Alessandro Rimessi, Gaia Pedriali, Bianca Vezzani, et al.
Seminars in Cell and Developmental Biology (2019) Vol. 98, pp. 167-180
Open Access | Times Cited: 38
The hepato-protective effect of H2S-modified and non-modified mesenchymal stem cell exosomes on liver ischemia-reperfusion injury in mice: The role of MALAT1
Maryam Jafar Sameri, Feryal Savari, Khojasteh Hoseinynejad, et al.
Biochemical and Biophysical Research Communications (2022) Vol. 635, pp. 194-202
Closed Access | Times Cited: 22
Programmed cell death in cerebellar Purkinje neurons
Nour S. Erekat
Journal of Integrative Neuroscience (2022) Vol. 21, Iss. 1, pp. 030-030
Open Access | Times Cited: 19
Overview of Targeted Drugs for Mature B-Cell Non-hodgkin Lymphomas
Stefania Crisci, Raffaele Di Francia, Sara Mele, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 31
Page 1 - Next Page

Scroll to top